title: British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.
authors.affiliation: Department of Cardiovascular Sciences, University of Leicester, Clinical Sciences Building, Leicester Royal Infirmary, Leicester. bw17@le.ac.uk
authors.forename: Bryan
authors.initials: B
authors.lastname: Williams
authors.forename: Neil R
authors.initials: NR
authors.lastname: Poulter
authors.forename: Morris J
authors.initials: MJ
authors.lastname: Brown
authors.forename: Mark
authors.initials: M
authors.lastname: Davis
authors.forename: Gordon T
authors.initials: GT
authors.lastname: McInnes
authors.forename: John F
authors.initials: JF
authors.lastname: Potter
authors.forename: Peter S
authors.initials: PS
authors.lastname: Sever
authors.forename: Simon McG
authors.initials: SM
authors.lastname: Thom
mesh_terms: D000465:Algorithms; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001795:Blood Pressure Determination / Q000379:methods; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006973:Hypertension / Q000517:prevention & control / Q000628:therapy*; D008019:Life Style; D008487:Medical History Taking / Q000379:methods; D010808:Physical Examination / Q000379:methods; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D018570:Risk Assessment
chemical_list: D000959:Antihypertensive Agents; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors; D001241:Aspirin